+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Efficacy of alternate-day dosing versus daily dosing of atorvastatin

Efficacy of alternate-day dosing versus daily dosing of atorvastatin

Journal of Cardiovascular Pharmacology & Therapeutics 8(2): 123-126

Background: Atorvastatin is a synthetic inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase. In placebo-controlled trials, it has been shown to achieve significant dose-dependent reductions in low-density lipoprotein cholesterol, total cholesterol, and triglycerides. This trial compared the efficacy of daily atorvastatin administration with that of alternate-day dosing. Methods: This was a randomized, prospective, nonblinded, controlled clinical trial. Fifty-four patients with low-density lipoprotein cholesterol of 100 to 200 mg/dL were enrolled. Baseline fasting lipid profile (total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and triglycerides), liver function tests (aspartate transaminase and alanine aminotransferase), and creatine kinase were drawn. Patients were randomized to three atorvastatin dose groups. Group I received 10 mg of atorvastatin every day, Group II received 10 mg every other day, and Group III received 20 mg every other day. After 6 weeks of treatment with atorvastatin, fasting lipid profiles, liver function tests, and creatine kinase concentrations were redrawn. Compliance to treatment was assessed at each visit. Results: Of the 54 patients enrolled, 46 completed the study. All three regimens significantly reduced total cholesterol and low-density lipoprotein cholesterol compared to baseline. No statistically significant differences existed between the three groups in regards to total, or a percentage, decrease in total cholesterol and low-density lipoprotein cholesterol at 6 weeks compared to baseline. All regimens were well tolerated and none of the patients had a significant elevation of liver enzymes or creatine kinase during the course of the study. Conclusion: Alternate-day dosing of atorvastatin is an efficacious and safe alternative to daily dosing.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 010569843

Download citation: RISBibTeXText

PMID: 12808485

DOI: 10.1177/107424840300800205

Related references

Is alternate day dosing of atorvastatin effective in managing patients with hyperlipidemia? The alternate day versus daily dosing of atorvastatin study. Journal of the American College of Cardiology 37(2 Suppl. A): 300A, 2001

Is alternate daily dose of atorvastatin effective in treating patients with hyperlipidemia? The alternate day versus daily dosing of atorvastatin study (ADDAS). American Heart Journal 144(4): 674-677, 2002

Comparative efficacy of daily versus alternate-day dosing of atorvastatin in Type 2 diabetic patients. Therapy 4(5): 541-545, 2007

Efficacy of alternate-day versus everyday dosing of atorvastatin. Indian Journal of Pharmacology 44(3): 362-365, 2012

Daily dosing versus alternate-day dosing of simvastatin in patients with hypercholesterolemia. Pharmacotherapy 22(9): 1110-1116, 2002

Comparison of serum concentrations with daily cefonicid dosing versus alternate day dosing plus probenecid. Clinical Pharmacology & Therapeutics 41(2): 195, 1987

Efficacy of alternate day versus daily dosing of rosuvastatin. Canadian Journal of Cardiology 25(2): E28-E31, 2009

A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides. Clinical Infectious Diseases 24(5): 796-809, 1997

Efficacy and safety of 48 weeks of enfuvirtide 180 mg once-daily dosing versus 90 mg twice-daily dosing in HIV-infected patients. HIV Clinical Trials 9(2): 73-82, 2008

Gentamicin and clindamycin therapy in postpartum endometritis: The efficacy of daily dosing versus dosing every 8 hours. American Journal of Obstetrics & Gynecology 188(1): 149-152, 2003

Efficacy and Safety of Alternate-Day Versus Daily Dosing of Statins: a Systematic Review and Meta-Analysis. Cardiovascular Drugs and Therapy 31(4): 419-431, 2017

Efficacy of alternate day dosing of atorvastatin. Central European Journal of Medicine 3(2): 163-166, 2008

Alternate-day dosing of statins for secondary prevention of coronary artery disease/The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels. Anadolu Kardiyoloji Dergisi 9(3): 253; Author Reply 253-4, 2009

Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humans. Psychopharmacology. 136(3): 217-225, Il, 1998

Weekly versus daily dosing of atorvastatin. Journal of Family Practice 51(4): 365-366, 2002